Yestar Healthcare Holdings Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Changxiang Liao
Chief executive officer
CN¥1.6m
Total compensation
| CEO salary percentage | 91.9% |
| CEO tenure | 2.3yrs |
| CEO ownership | n/a |
| Management average tenure | 2.7yrs |
| Board average tenure | 2.6yrs |
Recent management updates
Recent updates
These 4 Measures Indicate That Yestar Healthcare Holdings (HKG:2393) Is Using Debt Extensively
Nov 21
Yestar Healthcare Holdings' (HKG:2393) Attractive Earnings Are Not All Good News For Shareholders
Sep 19Yestar Healthcare Holdings (HKG:2393) Seems To Be Using A Lot Of Debt
Dec 13These Return Metrics Don't Make Yestar Healthcare Holdings (HKG:2393) Look Too Strong
Oct 18Is Yestar Healthcare Holdings (HKG:2393) Using Too Much Debt?
Sep 05One Yestar Healthcare Holdings Company Limited (HKG:2393) Analyst Has Been Cutting Their Forecasts
Sep 05Returns On Capital At Yestar Healthcare Holdings (HKG:2393) Have Hit The Brakes
Jun 10These 4 Measures Indicate That Yestar Healthcare Holdings (HKG:2393) Is Using Debt Extensively
Apr 18What Kind Of Investors Own Most Of Yestar Healthcare Holdings Company Limited (HKG:2393)?
Mar 15The Returns At Yestar Healthcare Holdings (HKG:2393) Provide Us With Signs Of What's To Come
Feb 07A Look At Yestar Healthcare Holdings' (HKG:2393) Share Price Returns
Dec 21Do Institutions Own Yestar Healthcare Holdings Company Limited (HKG:2393) Shares?
Nov 30
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | CN¥1b |
| Mar 31 2024 | n/a | n/a | CN¥534m |
| Dec 31 2023 | CN¥2m | CN¥2m | -CN¥9m |
| Jun 30 2023 | n/a | n/a | -CN¥294m |
| Mar 31 2023 | n/a | n/a | -CN¥377m |
| Dec 31 2022 | CN¥1m | CN¥854k | -CN¥460m |
| Sep 30 2022 | n/a | n/a | -CN¥633m |
| Jun 30 2022 | n/a | n/a | -CN¥274m |
| Mar 31 2022 | n/a | n/a | -CN¥135m |
| Dec 31 2021 | CN¥1m | CN¥867k | CN¥3m |
| Sep 30 2021 | n/a | n/a | CN¥83m |
| Jun 30 2021 | n/a | n/a | CN¥162m |
| Mar 31 2021 | n/a | n/a | -CN¥214m |
| Dec 31 2020 | CN¥833k | CN¥686k | -CN¥590m |
Compensation vs Market: Changxiang's total compensation ($USD225.60K) is about average for companies of similar size in the Hong Kong market ($USD230.70K).
Compensation vs Earnings: Changxiang's compensation has been consistent with company performance over the past year.
CEO
Changxiang Liao (49 yo)
2.3yrs
Tenure
CN¥1,646,000
Compensation
Ms. Changxiang Liao serves as Chief Executive Officer at Yestar Healthcare Holdings Company Limited since August 24, 2022, also serves as an Executive Director since November 2, 2020. She serves as General...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Executive Director | 2.3yrs | CN¥1.65m | no data | |
| CFO & Executive Director | less than a year | no data | no data | |
| Chief Operating Officer | 6.8yrs | CN¥2.76m | no data | |
| Company Secretary | 3yrs | no data | no data |
2.7yrs
Average Tenure
45.5yo
Average Age
Experienced Management: 2393's management team is considered experienced (2.7 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Executive Director | 4.1yrs | CN¥1.65m | no data | |
| CFO & Executive Director | less than a year | no data | no data | |
| Non-Executive Chairman | 12.8yrs | CN¥3.15m | 19.5% HK$ 29.6m | |
| Independent Non-Executive Director | 3.6yrs | CN¥204.00k | no data | |
| Independent Non-Executive Director | 1.6yrs | CN¥116.00k | no data | |
| Independent Non-Executive Director | 1.6yrs | CN¥116.00k | no data |
2.6yrs
Average Tenure
48.5yo
Average Age
Experienced Board: 2393's board of directors are not considered experienced ( 2.6 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 02:58 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Yestar Healthcare Holdings Company Limited is covered by 10 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Paul Rodger Snelgrove | CGS International |
| Timothy Lee | CLSA |
| Jie Sheng Liu | Credit Suisse |